Zynex Inc ROCE
Qual é o ROCE de Zynex Inc?
O ROCE de Zynex Inc é 9.98%
Qual é a definição de ROCE?
O retorno sobre o capital empregado (ROCE) é um índice financeiro que mede a lucratividade de uma empresa e a eficiência com que seu capital é usado.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE de empresas na Setor Health Care em NASDAQ em comparação com Zynex Inc
O que Zynex Inc faz?
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
Empresas com roce semelhantes a Zynex Inc
- Safran SA tem ROCE de 9.96%
- Societe de Services, de Participations, de Direction et d'Elaboration tem ROCE de 9.96%
- Western Union tem ROCE de 9.96%
- SMTC tem ROCE de 9.97%
- Navios Maritime Partners L.P tem ROCE de 9.97%
- Georgia Healthcare Plc tem ROCE de 9.97%
- Zynex Inc tem ROCE de 9.98%
- Henry Schein tem ROCE de 9.99%
- Albertsons Companies tem ROCE de 9.99%
- Schaeffler AG tem ROCE de 10.00%
- Century Communities Inc tem ROCE de 10.00%
- Ambuja Cements tem ROCE de 10.00%
- Nortech Systems tem ROCE de 10.01%